TENS for MS: scientists peek inside the brain to see if it works
NCT ID NCT06432686
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This pilot study will use brain scans (fMRI) to understand how transcutaneous electrical nerve stimulation (TENS) affects brain activity in 30 people with multiple sclerosis (MS). TENS is a safe, home-use device that sends mild electrical pulses through the skin. The goal is to learn why TENS might reduce fatigue and walking problems, not yet to prove it works as a treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Transcutaneous Electrical Nerve Stimulation (TENS)
What this could lead to
If successful, this study could clarify how TENS works in the brain, paving the way for larger trials to test it as a home-based treatment for MS-related fatigue and walking difficulty.
What could go wrong
This is a very small pilot study (30 people) focused on brain imaging, not on proving TENS actually improves symptoms. The results may not translate into real-world benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••